✦ LIBER ✦

Noncirrhotic Portal Hypertension in Congenital Cytomegalovirus Infection

✍ Scribed by Fayez K. Ghishan; Harry L. Greene; Susan Halter; John A. Barnard; J. Roberto Moran

Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 310 KB
Volume: 4
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840040420

No coin nor oath required. For personal study only.

✦ Synopsis

The majority of infants with cytomegalovirus hepatitis have resolution of the disease with little evidence of fibrosis; there are only rare instances of cirrhosis. We report an infant with cytomegalovirus hepatitis who developed portal hypertension and hematemesis at 3 months of age. Liver biopsy showed resolution of the hepatitis but the presence of noncirrhotic sinusoidal fibrosis. Because of recurrent hematemesis in spite of sclerosing therapy on two occasions, the beta antagonist propranolol was begun. Hepatic wedge pressures before and after treatment with propranolol were 13 and 7 mm Hg, respectively. The findings emphasize: (i) that cytomegalovirus hepatitis may result in noncirrhotic sinusoidal fibrosis and (ii) that propranolol may be beneficial in the management of portal hypertension secondary to noncirrhotic sinusoidal fibrosis.

📜 SIMILAR VOLUMES

Noncirrhotic portal hypertension in a ch

Noncirrhotic portal hypertension in a child with velocardiofacial syndrome

✍ Laurie H. Seaver; Janet M. Brumblay; Claire M. Wilson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 1 views

Idiopathic noncirrhotic intrahepatic por

Idiopathic noncirrhotic intrahepatic portal hypertension is an ongoing problem in India

✍ Ashish Goel; Banumathi Ramakrishna; Kadiyala Madhu; Uday Zachariah; Jeyamani Ram 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

We read with great interest the recent report by Li et al. 1 analyzing the correlation between the clusters of differentiation 24 (CD24) polymorphism and risk of chronic hepatitis B virus (HBV) infection. In their study, the CD24 P170 T allele (thymidine at position 170) was correlated with a strong

Noncirrhotic presinusoidal portal hypert

Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis–associated liver disease

✍ Peter Witters; Louis Libbrecht; Tania Roskams; Kris De Boeck; Lieven Dupont; Mar 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 632 KB

Shorter duration and lower dose of peginterferon alfa-2a therapy results in inferior HBeAg seroconversion rates compared with the duration and dose of 48 weeks and 180 lg: NEPTUNE study.

Histopathological study of intrahepatic

Histopathological study of intrahepatic aberrant vessels in cases of noncirrhotic portal hypertension

✍ Makoto Ohbu; Masahiko Okudaira; Kiyoharu Watanabe; Satoshi Kaneko; Tomoko Takai 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 777 KB

Aberrant vessels, which are defined as dilated blood vessels immediately adjacent to the peripheral portal tract, appear under conditions of extrahepatic portal obstruction and nodular regenerative hyperplasia as well as idiopathic portal hypertension. Our study was

Idiopathic portal hypertension (noncirrh

Idiopathic portal hypertension (noncirrhotic portal fibrosis), thrombosis in portal venous system and protein C deficiency to the editor

✍ N. C. Nayak 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

Endothelin-1 modulates intrahepatic resi

Endothelin-1 modulates intrahepatic resistance in a rat model of noncirrhotic portal hypertension

✍ Patrick S. Kamath; Gertrude M. Tyce; Virginia M. Miller; Brooks S. Edwards; Duan 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 409 KB

Factors that increase resistance to blood flow through the hepatic sinusoids when portal hypertension occurs in the absence of significant hepatic fibrosis are not completely understood. Experiments were designed to test the hypothesis that endothelin-1 (ET-1) is one of the humoral factors that incr